Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. - Husain MI; Blumberger DM; Castle DJ; Ledwos N; Fellows E; Jones BDM; Ortiz A; Kloiber S; Wang W; Rosenblat JD; Mulsant BH (BJPsych open, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com